Salts of AT₂ receptor inhibitors, their solid forms, preparation methods, and uses

TW202635675APending Publication Date: 2026-09-01BEIJING TIDE PHARMACEUTICAL CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114141133
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-10-24
Filing Date
2025-10-23
Publication Date
2026-09-01

Smart Images

  • Figure TWG2TA001074474_001
    Figure TWG2TA001074474_001
  • Figure TWG2TA001074474_002
    Figure TWG2TA001074474_002
  • Figure TWG2TA001074474_003
    Figure TWG2TA001074474_003
Patent Text Reader

Abstract

This invention relates to salts of AT2 receptor inhibitors, their solid forms, methods for their preparation, and uses, specifically to salts of (1R, 2S, 5S)-3-[(diphenylamino)carbonyl]-8-{[methyl(phenylmethyl)amino]carbonyl}-3,8-diazabicyclo[3.2.1]octane-2-carboxylic acid (compound A) and their solid forms, methods for preparing said solid forms, pharmaceutical compositions comprising said solid forms, and the use of said solid forms in the preparation of medicaments used as AT2 receptor inhibitors.
Need to check novelty before this filing date? Find Prior Art